[go: up one dir, main page]

AU2001247471A1 - Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones - Google Patents

Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones

Info

Publication number
AU2001247471A1
AU2001247471A1 AU2001247471A AU4747101A AU2001247471A1 AU 2001247471 A1 AU2001247471 A1 AU 2001247471A1 AU 2001247471 A AU2001247471 A AU 2001247471A AU 4747101 A AU4747101 A AU 4747101A AU 2001247471 A1 AU2001247471 A1 AU 2001247471A1
Authority
AU
Australia
Prior art keywords
polymethoxyflavones
disorders
compositions
treating
reducing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001247471A
Inventor
Najla Guthrie
Robert M. Horowitz
Elzbieta Maria Kurowska
John A. Manthey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KGK SYNERGIE
US Department of Agriculture USDA
Original Assignee
KGK SYNERGIE
US Department of Agriculture USDA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/528,488 external-priority patent/US6987125B1/en
Application filed by KGK SYNERGIE, US Department of Agriculture USDA filed Critical KGK SYNERGIE
Publication of AU2001247471A1 publication Critical patent/AU2001247471A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001247471A 2000-03-17 2001-03-16 Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones Abandoned AU2001247471A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/528,488 US6987125B1 (en) 1998-10-06 2000-03-17 Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones
US09528488 2000-03-17
PCT/US2001/008395 WO2001070029A1 (en) 2000-03-17 2001-03-16 Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones

Publications (1)

Publication Number Publication Date
AU2001247471A1 true AU2001247471A1 (en) 2001-10-03

Family

ID=24105873

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001247471A Abandoned AU2001247471A1 (en) 2000-03-17 2001-03-16 Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones

Country Status (4)

Country Link
EP (1) EP1278417A1 (en)
AU (1) AU2001247471A1 (en)
CA (1) CA2403548A1 (en)
WO (1) WO2001070029A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6987125B1 (en) 1998-10-06 2006-01-17 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones
US7201928B1 (en) 1999-09-21 2007-04-10 Rutgers, The State University Of New Jersey Extracts of orange peel for prevention and treatment of cancer
MXPA03010080A (en) * 2001-05-02 2006-04-05 Kgk Synergize Inc Use of polymethoxylated flavones for treating insulin resistance.
WO2005115377A1 (en) * 2004-05-26 2005-12-08 Kgk Synergize Inc Functional foods comprising flavonoids and tocotrienols and methods thereof
ATE491447T1 (en) * 2004-05-26 2011-01-15 Kgk Synergize Inc COMPOSITIONS CONTAINING FLAVONOIDS AND TOCOTRIENOLS AND USES THEREOF
JP2008513349A (en) * 2005-05-24 2008-05-01 ケージーケー シナジャイズ インコーポレイテッド Functional food containing flavonoid and tocotrienol and method thereof
US7887852B2 (en) 2005-06-03 2011-02-15 Soft Gel Technologies, Inc. Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols
BRPI0708893A2 (en) * 2006-03-15 2011-06-28 Univ Rutgers composition, processes for increasing the ratio of hydroxylated pmfs to nonhydroxylated pmfs in a plant extract, and for preparing the plant extract, uses of a hydroxylated pmfs, and a composition, and methods for inhibiting proliferation of a cancer cell , to induce apoptosis in a cancer cell, to reduce nitrite production in a macrophage, and to inhibit activation of inos and / or cox-2 in a macrophage.
KR101340675B1 (en) 2011-12-05 2013-12-12 대구한의대학교산학협력단 Pharmaceutical composition comprising tangeretin for preventing or treating cardiovascular diseases
US9132117B2 (en) 2013-06-17 2015-09-15 Kgk Synergize, Inc Compositions and methods for glycemic control of subjects with impaired fasting glucose

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867541A (en) * 1972-05-03 1975-02-18 Ralph C Robbins Compositions and methods for disaggregating blood cells

Also Published As

Publication number Publication date
CA2403548A1 (en) 2001-09-27
EP1278417A1 (en) 2003-01-29
WO2001070029A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
AU3998400A (en) Methods of treating c1s-mediated diseases and conditions, and compounds and compositions therefor
AU2002256359A1 (en) Antisense and anti-inflammatory based compositions to treat respiratory disorders
AU2001243219A1 (en) Methods of prevention and treatment of asthma, and allergic conditions
AU8003800A (en) Methods and compositions for treating neurobehavioral disorders
AU4205100A (en) Methods and compositions for the treatment of pancreatitis
AU2003213787A1 (en) Compositions and methods for the treatment of anorectal disorders
AU4229200A (en) Methods and compositions for treating dermatological disorders with fruit extracts
AU7360000A (en) Methods and compositions for preventing and treating prostate disorders
AUPR101600A0 (en) Compositions and methods for diagnosis and treatment of cardiovascular disorders
AU2003212850A1 (en) Methods and compositions for treating cardiovascular disease
AU2002235692A1 (en) Methods and compositions for preventing and treating neutrophil-mediated diseases
AU2002230888A1 (en) Methods and compositions to treat conditions associated with neovascularization
AU2001247471A1 (en) Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones
AU2001242130A1 (en) Novel derivatives comprising phytosterols and/or phytostanols and alpha-lipoic and use thereof in treating or preventing cardiovascular disease, its underlying conditions and other disorders
AU2002363935A1 (en) Composition and method for the treatment of anorectal disorders
AU2002365936A1 (en) Compositions and methods to treat gastrointestinal disorders
AU2002366809A1 (en) Syn3 compositions and methods
AU2002360531A1 (en) Methods and compositions to treat cardiovascular disease using 1419, 58765 and 2201
AUPQ872800A0 (en) Compositions and methods for treating cardiovascular disorders
HK1054295A (en) Compositions and methods of treating, reducing, and preventing cardiovascular diseases and disorders with polymethoxyflavones
AU2002210763A1 (en) Use of 1-ebio in the treatment of bipolar disorders
EP1315499A4 (en) Compositions and methods for the treatment of anorectal disorders
AU2002256967A1 (en) Treating or reducing the risk of cardiovascular disease
AU2002360343A1 (en) Methods and compositions to treat cardiovascular disease using 139, 258, 1261, 1486, 2398, 2414, 7660, 8587, 10183, 10550, 12680, 17921, 32248, 60489 or 93804
AU2000265105A1 (en) Methods and compositions for the prevention and treatment of syndrome x